Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Archives of Pathology & Laboratory Medicine|April 9, 2019
Anastomosing Hemangioma: Short Review of a Benign Mimicker of AngiosarcomaEleni Lappa, Elias DrakosFrontiers in Bioscience (Elite Edition)|December 29, 2015
The emerging role of CD30 and p53 as novel targets for therapy in anaplastic large cell lymphomaGeorge Z Rassidakis, Elias DrakosCancers|August 4, 2019
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and CancerKonstantina Georgila, Dimitra Vyrla, Elias DrakosExpert Reviews in Molecular Medicine|February 5, 2008
Mammalian target of rapamycin (mTOR) pathway signalling in lymphomasElias Drakos, George Z Rassidakis, L Jeffrey MedeirosNeurochemical Research|January 18, 2014
Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissuesCleanthe Spanaki, Dimitra Kotzamani, Zoe Petraki, et al.Molecular and Cellular Endocrinology|August 5, 2015
Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissuesCleanthe Spanaki, Dimitra Kotzamani, Zoe Petraki, et al.In Vivo (Athens, Greece)|December 29, 2015
Solid Organ Cool-tip Radiofrequency Ablation: An Experimental Study with Clinicopathological CorrelationsMichalis Kontos, Elias Drakos, Apostolos Papalois, et al.In Vivo (Athens, Greece)|June 21, 2002
Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasisChand Khanna, Jerry J Jaboin, Elias Drakos, et al.Human Pathology|February 17, 2007
Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomasElias Drakos, George Z Rassidakis, Vasiliki Leventaki, et al.The American Journal of Pathology|December 7, 2006
Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphomaEvangelia Peponi, Elias Drakos, Guadalupe Reyes, et al.Pageof 7